Treatment Response, Symptom Remission, and Wellness in Obsessive-Compulsive Disorder

被引:167
作者
Farris, Samantha G. [1 ]
McLean, Carmen P. [1 ]
Van Meter, Page E. [2 ]
Simpson, Helen Blair [2 ]
Foa, Edna B. [1 ]
机构
[1] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
[2] Columbia Univ, New York State Psychiat Inst, New York, NY USA
关键词
QUALITY-OF-LIFE; SIGNAL-DETECTION ANALYSIS; SOCIAL-ADJUSTMENT; CONTROLLED-TRIAL; PANIC DISORDER; DOUBLE-BLIND; PHARMACOTHERAPY; IMPAIRMENT; SCALE;
D O I
10.4088/JCP.12m07789
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Obsessive-compulsive disorder (OCD) is defined both by intrusive, unwanted thoughts, images, or impulses and by repetitive behavioral or mental acts that are often performed to try to alleviate anxiety. The ultimate goal of treatment for OCD is to reduce the symptoms as well as help patients achieve"wellness."Currently, however, there are no widely accepted, empirically supported criteria for determining wellness in OCD. Method: Building on previous research, the current study. examined the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score that most reliably identified patients who responded to treatment, those who achieved symptom remission, and those who achieved wellness. The current study pooled data from 4 randomized controlled OCD treatment trials (N=288), which took place between 1990 and 2011 at 2 academic sites. Participants (mean age =36.8 years) had a primary diagnosis of DSM-IV-TR OCD (mean Y-BOCS score =25.9). Results: Signal detection analyses showed that a pretreatment-to-posttreatment reduction of 35% on the Y-BOCS was most predictive of treatment response as defined by the Clinical Global Impressions (CGI)-Improvement scale. A posttreatment Y-BOCS score of <= 14 was the best predictor of symptom remission, whereas a score of 12 was the best predictor of wellness, as defined by symptom remission (defined by the CGI-Severity scale), good quality of life (as measured by the Quality of Life Enjoyment and Satisfaction Questionnaire), and a high level of adaptive functioning (as assessed by the Social Adjustment Scale-Self-Report). Because efficiency (0.86) and specificity (0.88) were highest at the cutoff of 12, this cutoff score was determined to be the best indicator of wellness. Conclusions:The present findings support the convergent validity of the Y-BOCS with other measures of well-being (quality of life, adaptive functioning) and highlight the utility of a Y-BOCS score <= 12 as a solo indicator of wellness in outcome studies, The use of empirically supported criteria for defining wellness in OCD is recommended to facilitate comparisons across treatment outcome studies and to inform clinical treatment planning.
引用
收藏
页码:685 / 690
页数:6
相关论文
共 37 条
  • [1] [Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
  • [2] What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow, Borwin
    Baldwin, David S.
    Dolberg, Ornah T.
    Andersen, Henning Friis
    Stein, Dan J.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (09) : 1428 - 1434
  • [3] Sertraline and fluoxetine treatment of obsessive-compulsive disorder: Results of a double-blind, 6-month treatment study
    Bergeron, R
    Ravindran, AV
    Chaput, Y
    Goldner, E
    Swinson, R
    van Ameringen, MA
    Austin, C
    Hadrava, V
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (02) : 148 - 154
  • [4] Quality-of-life changes among patients with obsessive-compulsive disorder in a partial hospitalization program
    Bystritsky, A
    Saxena, S
    Maidment, K
    Vapnik, T
    Tarlow, G
    Rosen, R
    [J]. PSYCHIATRIC SERVICES, 1999, 50 (03) : 412 - 414
  • [5] Quality of life in panic disorder: looking beyond symptom remission
    Davidoff, Julia
    Christensen, Scott
    Khalili, David N.
    Jaidyn Nguyen
    IsHak, Waguih William
    [J]. QUALITY OF LIFE RESEARCH, 2012, 21 (06) : 945 - 959
  • [6] A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder
    Eddy, KT
    Dutra, L
    Bradley, R
    Westen, D
    [J]. CLINICAL PSYCHOLOGY REVIEW, 2004, 24 (08) : 1011 - 1030
  • [7] ENDICOTT J, 1993, PSYCHOPHARMACOL BULL, V29, P321
  • [8] Fischer J, 1994, MEASURES CLIN PRACTI, V2, P580
  • [9] Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder
    Foa, EB
    Liebowitz, MR
    Kozak, MJ
    Davies, S
    Campeas, R
    Franklin, ME
    Huppert, JD
    Kjernisted, K
    Rowan, V
    Schmidt, AB
    Simpson, HB
    Tu, X
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (01) : 151 - 161
  • [10] Quality of life: Expanding the scope of clinical significance
    Gladis, MM
    Gosch, EA
    Dishuk, NM
    Crits-Christoph, P
    [J]. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1999, 67 (03) : 320 - 331